DK0920426T3 - Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning - Google Patents

Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning

Info

Publication number
DK0920426T3
DK0920426T3 DK97940080T DK97940080T DK0920426T3 DK 0920426 T3 DK0920426 T3 DK 0920426T3 DK 97940080 T DK97940080 T DK 97940080T DK 97940080 T DK97940080 T DK 97940080T DK 0920426 T3 DK0920426 T3 DK 0920426T3
Authority
DK
Denmark
Prior art keywords
inhibitory effect
thiazole derivatives
pct
phosphodiesterase inhibitory
novel thiazole
Prior art date
Application number
DK97940080T
Other languages
English (en)
Inventor
Hermann Amschler
Thomas Martin
Beate Schmidt
Hildegard Boss
Thomas Baer
Wolf-Ruediger Ulrich
Dietrich Haefner
Dieter Flockerzi
Ulrich Thibaut
Armin Hatzelmann
Hans-Peter Kley
Rolf Beume
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK0920426T3 publication Critical patent/DK0920426T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK97940080T 1996-08-26 1997-08-13 Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning DK0920426T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19634411 1996-08-26
EP96113737 1996-08-28
PCT/EP1997/004435 WO1998008841A1 (de) 1996-08-26 1997-08-13 Neue thiazol-derivate mit phosphodiesterase inhibierender wirkung

Publications (1)

Publication Number Publication Date
DK0920426T3 true DK0920426T3 (da) 2004-02-02

Family

ID=26028746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97940080T DK0920426T3 (da) 1996-08-26 1997-08-13 Hidtil ukendte thiazolderivater med phosphodiesteraseinhiberende virkning

Country Status (12)

Country Link
US (1) US6011037A (da)
EP (1) EP0920426B9 (da)
JP (1) JP2000516940A (da)
AT (1) ATE251153T1 (da)
AU (1) AU4205197A (da)
CY (1) CY2509B1 (da)
DE (1) DE59710816D1 (da)
DK (1) DK0920426T3 (da)
ES (1) ES2208950T3 (da)
PT (1) PT920426E (da)
SI (1) SI0920426T1 (da)
WO (1) WO1998008841A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2715683A1 (en) 1999-08-21 2001-03-01 Nycomed Gmbh Synergistic combination
WO2003015776A1 (en) 2001-08-13 2003-02-27 Janssen Pharmaceutica N.V. 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
EA200501548A1 (ru) 2003-04-01 2006-02-24 Апплайд Резеч Системз Арс Холдинг Н.В. Ингибиторы фосфодиэстераз при бесплодии
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2643199A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2068872A1 (en) * 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP2066355A2 (en) * 2006-09-19 2009-06-10 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CA2834062A1 (en) 2011-05-10 2012-11-15 Merck Sharp & Dohme Corp. Pyridyl aminopyridines as syk inhibitors
US9145391B2 (en) 2011-05-10 2015-09-29 Merck Sharp & Dohme Corp. Bipyridylaminopyridines as Syk inhibitors
AU2012253885A1 (en) 2011-05-10 2013-10-31 Merck Sharp & Dohme Corp. Aminopyrimidines as Syk inhibitors
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2074933C (en) * 1990-11-30 2002-12-03 Masatoshi Chihiro Thiazole derivatives as active superoxide radical inhibitors
WO1993024472A1 (fr) * 1992-05-29 1993-12-09 Otsuka Pharmaceutical Co., Ltd. Derive de thiazole
GB9315017D0 (en) * 1993-07-20 1993-09-01 Glaxo Lab Sa Chemical compounds
WO1996003392A1 (en) * 1994-07-27 1996-02-08 G.D. Searle & Co. Substituted thiazoles for the treatment of inflammation

Also Published As

Publication number Publication date
AU4205197A (en) 1998-03-19
ES2208950T3 (es) 2004-06-16
EP0920426A1 (de) 1999-06-09
SI0920426T1 (en) 2004-04-30
JP2000516940A (ja) 2000-12-19
CY2509B1 (en) 2005-12-23
WO1998008841A1 (de) 1998-03-05
ATE251153T1 (de) 2003-10-15
EP0920426B1 (de) 2003-10-01
US6011037A (en) 2000-01-04
PT920426E (pt) 2004-02-27
EP0920426B9 (de) 2005-04-06
DE59710816D1 (de) 2003-11-06

Similar Documents

Publication Publication Date Title
CY2509B1 (en) New thiazole derivatives with phosphodiesterase-inhibitting effect
ATE233247T1 (de) Phtalazinonen
DK1070056T3 (da) Phthalazinon-PDE III/IV-inhibitorer
DK1000035T3 (da) Substituerede 6-phenylphenanthridiner
MX9700557A (es) Dihidrobenzofuranos.
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
DE69719358D1 (de) Substituierte dihydrobenzofurane als pde-hemmstoffe
DK1003724T3 (da) Substituerede quinolin-derivater med antiviral virkning
TW282458B (da)
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.